Professor Jacob See-Tong Pang graduated from Chung-Shan Medical University, Taichung, Taiwan. Upon completion of his medical and surgical residency training and driven by his strong interest in medical research, he pursued his advanced study at the Karolinska Institute, Sweden and obtained his PhD degree in 2003. He was the chief of Department of Uro-Oncology at Chang Gung Memorial Hospital from 2007 to 2014, and vice-superintendent of the Chang Gung Memorial Hospital (CGMH), LinKou from July 2017 till June 2023. He completed the first robotic surgery at Chang Gung Memorial Hospital in October, 2006, since then he has completed nearly 1500 robotic surgeries including prostatectomy, partial nephrectomy, cystectomy, nephroureterectomy and etc. Prof. Pang actively involves in both clinical and translation research. His research effort focuses on understanding and improving clinical outcomes of patients with urological cancer. Of note, he co-led the research team to elucidate the mutational signature of aristolochic acid-associated upper urinary tract urothelial cell carcinoma (UTUC) and published the results in Science Translational Medicine. Thus far, he has published more than 160 peer-reviewed articles in many renowned medical journals. He is also the immediate past president of Taiwan Urological Association(TUA), and currently the president-elect of Urological Association of Asia (UAA).